Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Grows By 21.9%

Nuwellis, Inc. (NASDAQ:NUWE) saw a large increase in short interest in June. As of June 30th, there was short interest totalling 73,600 shares, an increase of 21.9% from the June 15th total of 60,400 shares. Approximately 37.9% of the company’s stock are sold short. Based on an average daily volume of 232,000 shares, the short-interest ratio is presently 0.3 days.

Nuwellis Price Performance

NUWE stock traded up $0.10 during trading on Tuesday, hitting $4.33. 64,088 shares of the stock traded hands, compared to its average volume of 128,941. The stock has a market cap of $2.25 million, a price-to-earnings ratio of -0.01 and a beta of 0.44. Nuwellis has a 1 year low of $3.34 and a 1 year high of $98.35. The firm’s 50 day moving average is $7.14 and its two-hundred day moving average is $12.66.

Nuwellis (NASDAQ:NUWE) last posted its quarterly earnings results on Tuesday, May 7th. The company reported ($21.00) EPS for the quarter. Nuwellis had a negative net margin of 202.97% and a negative return on equity of 316.90%. The firm had revenue of $1.86 million for the quarter.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.